Wellington Management Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.41B Sell
8,228,537
-61,439
-0.7% -$20.2M 0.45% 43
2025
Q4
$2.91B Buy
8,289,976
+1,668,679
+25% +$564M 0.51% 31
2025
Q3
$2.14B Buy
6,621,297
+303,099
+5% +$94.3M 0.37% 57
2025
Q2
$2.46B Buy
6,318,198
+523,404
+9% +$211M 0.45% 48
2025
Q1
$2.52B Sell
5,794,794
-560,738
-9% -$225M 0.48% 48
2024
Q4
$2.34B Buy
6,355,532
+1,893,947
+42% +$793M 0.43% 57
2024
Q3
$2.32B Buy
4,461,585
+286,905
+7% +$153M 0.41% 59
2024
Q2
$2.26B Sell
4,174,680
-324,949
-7% -$172M 0.4% 54
2024
Q1
$2.33B Sell
4,499,629
-1,410,763
-24% -$702M 0.41% 52
2023
Q4
$2.79B Sell
5,910,392
-682,374
-10% -$316M 0.52% 41
2023
Q3
$2.87B Sell
6,592,766
-733,347
-10% -$333M 0.57% 37
2023
Q2
$3.25B Sell
7,326,113
-1,130,951
-13% -$522M 0.62% 31
2023
Q1
$3.89B Sell
8,457,064
-325,001
-4% -$155M 0.77% 27
2022
Q4
$4.5B Sell
8,782,065
-418,973
-5% -$213M 0.9% 20
2022
Q3
$4.18B Sell
9,201,038
-646,793
-7% -$309M 0.89% 18
2022
Q2
$4.75B Sell
9,847,831
-281,590
-3% -$139M 0.96% 17
2022
Q1
$4.98B Sell
10,129,421
-233,870
-2% -$107M 0.85% 21
2021
Q4
$4.8B Sell
10,363,291
-115,928
-1% -$48.8M 0.77% 22
2021
Q3
$3.91B Sell
10,479,219
-222,546
-2% -$84.6M 0.66% 28
2021
Q2
$4.09B Sell
10,701,765
-103,067
-1% -$39.4M 0.68% 25
2021
Q1
$3.88B Buy
10,804,832
+800,998
+8% +$258M 0.68% 29
2020
Q4
$3.21B Buy
10,003,834
+498,228
+5% +$153M 0.59% 37
2020
Q3
$2.55B Sell
9,505,606
-1,029,928
-10% -$277M 0.53% 45
2020
Q2
$2.77B Sell
10,535,534
-804,426
-7% -$215M 0.62% 39
2020
Q1
$2.57B Buy
11,339,960
+3,297,783
+41% +$899M 0.68% 35
2019
Q4
$2.43B Sell
8,042,177
-460,592
-5% -$127M 0.51% 47
2019
Q3
$2.04B Buy
8,502,769
+457,149
+6% +$125M 0.46% 52
2019
Q2
$2.27B Sell
8,045,620
-124,731
-2% -$34.1M 0.5% 49
2019
Q1
$2.34B Buy
8,170,351
+2,139,472
+35% +$619M 0.53% 44
2018
Q4
$1.58B Buy
6,030,879
+1,376,582
+30% +$379M 0.4% 59
2018
Q3
$1.28B Buy
4,654,297
+348,986
+8% +$90.6M 0.27% 94
2018
Q2
$1.02B Buy
4,305,311
+600,817
+16% +$139M 0.23% 112
2018
Q1
$814M Sell
3,704,494
-202,211
-5% -$47.5M 0.18% 134
2017
Q4
$879M Sell
3,906,705
-340,259
-8% -$72.5M 0.19% 128
2017
Q3
$806M Sell
4,246,964
-70,677
-2% -$13.5M 0.19% 131
2017
Q2
$812M Sell
4,317,641
-125,519
-3% -$22.6M 0.19% 127
2017
Q1
$735M Buy
4,443,160
+1,548,077
+53% +$246M 0.18% 137
2016
Q4
$416M Sell
2,895,083
-635,140
-18% -$85M 0.1% 194
2016
Q3
$442M Sell
3,530,223
-478,644
-12% -$61.8M 0.11% 193
2016
Q2
$527M Sell
4,008,867
-66,133
-2% -$9.05M 0.14% 162
2016
Q1
$566M Sell
4,075,000
-54,678
-1% -$7.31M 0.15% 147
2015
Q4
$576M Buy
4,129,678
+8,547
+0.2% +$1.18M 0.15% 144
2015
Q3
$577M Buy
4,121,131
+45,375
+1% +$6.82M 0.16% 141
2015
Q2
$669M Sell
4,075,756
-219,391
-5% -$35.1M 0.17% 129
2015
Q1
$663M Buy
4,295,147
+585,450
+16% +$83.4M 0.17% 128
2014
Q4
$466M Sell
3,709,697
-44,192
-1% -$5.46M 0.12% 165
2014
Q3
$449M Sell
3,753,889
-216,820
-5% -$24.9M 0.12% 176
2014
Q2
$427M Buy
3,970,709
+22,031
+0.6% +$2.27M 0.11% 191
2014
Q1
$393M Sell
3,948,678
-2,848,188
-42% -$258M 0.11% 207
2013
Q4
$628M Sell
6,796,866
-662,664
-9% -$58.9M 0.18% 132
2013
Q3
$624M Sell
7,459,530
-336,931
-4% -$28.9M 0.2% 114
2013
Q2
$638M Buy
+7,796,461
New +$583M 0.21% 100

Other funds holding ELV

Wellington Management Group's ELV Position: Q1 2026 in Review

Wellington Management Group reduced its Elevance Health (ELV) stake by 0.74% in Q1 2026, selling an estimated $20.2M and leaving 8,228,537 shares worth $2.41B. The position accounts for 0.45% of the portfolio, ranked #43.

Wellington Management Group first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.98B in Q1 2022. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Wellington Management Group held 8,228,537 shares of Elevance Health worth $2.41B as of Q1 2026.
  • Wellington Management Group sold 61,439 Elevance Health shares in Q1 2026, an estimated $20.2M.
  • Elevance Health made up 0.45% of Wellington Management Group's portfolio in Q1 2026, its #43 holding.
  • Wellington Management Group first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
  • Wellington Management Group's Elevance Health position peaked at $4.98B in Q1 2022.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.